Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Addex Convenes Annual General Meeting 2024

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

Addex to Present at Bio€quity Europe 2024

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Addex to Present at the Swiss Biotech Day 2024

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Addex to Present at the Bio-Europe Spring 2024 Conference